PhRMA

NOVEMBER 9, 2022

The June decision by WTO members to waive commitments to protect intellectual property (IP) for COVID-19 vaccines under the Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement was a political and ineffective measure that does not address the true barriers to vaccine equity. Now, some are pushing to extend this harmful waiver to COVID-19 treatments, even though production exceeds demand for treatments, including for the most effective antivirals and monoclonal antibodies.

Vaccines 289

Vaccines 289

Drug Topics

NOVEMBER 11, 2022

CBD therapy has had positive outcomes in other inflammatory conditions.

227

227

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.

181

181

Fierce Pharma

NOVEMBER 10, 2022

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. aliu. Thu, 11/10/2022 - 09:02.

Vaccines 145

Vaccines 145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PhRMA

NOVEMBER 7, 2022

Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments. It’s important to consider the best available information and evidence when making health care decisions.

209

209

Drug Topics

NOVEMBER 10, 2022

Medication only works when it's taken, which makes adherence necessary. The approach can't be "one size fits all".

219

219

STAT

NOVEMBER 10, 2022

The country is heading into its third Covid winter without crucial tools we’ve relied on at previous points in the pandemic, both as governments roll back their responses and as the virus outruns some of our most important medicine-cabinet defenses. Free at-home tests are no longer showing up at people’s doorsteps. States are reporting outbreak data less frequently, and globally, testing and surveillance programs have been curtailed.

Vaccines 140

Vaccines Insurance 140

PhRMA

NOVEMBER 10, 2022

The Working for Cures Employee Champion Awards celebrate the real people in our industry who go above and beyond to advance science and support the work our industry does for patients.

208

208

Drug Topics

NOVEMBER 7, 2022

Cannabinoids lack the habit-forming mechanism of action found in methadone and buprenorphine, unlocking new potential for the drug.

212

212

Pharmacy Times

NOVEMBER 7, 2022

Although fentanyl is potent and often deadly, it is not passively absorbed into the bloodstream.

145

145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 10, 2022

SAN DIEGO — Rayyan Gorashi is keeping her options open. After all, she’s still a second-year bioengineering Ph.D. student at UC San Diego, and there are so many careers to explore. Patent law has been high up on her list ever since a class she took in college. There’s also regulatory affairs. Oh, and science publishing sounds interesting, too.

140

140

PhRMA

NOVEMBER 8, 2022

Our health care ecosystem has made tremendous progress in the fight against cancer, with the cancer death rate falling 32% from its peak in 1991. On November 3, PhRMA sponsored The Atlantic’s People v. Cancer event, hosting the session PhRMA Presents: The Future of Fighting Cancer. PhRMA’s COO Lori Reilly, Esq., spoke with Eli Lilly and Company’s Jacob Van Naarden, CEO of Loxo@Lilly, about the incredible advancements made in cancer treatment.

208

208

Drug Topics

NOVEMBER 9, 2022

Many diabetes patients are rationing supplies, putting off purchasing them, or completely forgoing them because of costs.

201

201

Pharmacy Times

NOVEMBER 6, 2022

Controlling blood pressure may be the most important type of treatment for vasculitis and lupus patients, said a professor of renal medicine at ASN Kidney Week in Orlando, Florida.

145

145

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

NOVEMBER 9, 2022

Experts urge polio vaccination to ward off any major resurgence. fdiamond. Wed, 11/09/2022 - 15:06.

Vaccines 135

Vaccines 135

PhRMA

NOVEMBER 10, 2022

Have you ever noticed that one medicine might be used to treat two, three, seven different conditions? That’s the result of significant additional research and investment, including lengthy and costly clinical trials, biopharmaceutical companies undertake after a medicine is initially approved by the Food and Drug Administration (FDA). Such post approval R&D has changed the course of treatment for many diseases and patient populations.

FDA 181

FDA 181

Drug Topics

NOVEMBER 10, 2022

For pharmacy owners, understanding tax code can lead to financial benefits at tax time.

201

201

Pharmacy Times

NOVEMBER 10, 2022

Study shows there are 2.5 times more breast cancer survivors since the last estimate was conducted in 2007.

139

139

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Healthcare

NOVEMBER 7, 2022

UnitedHealth continues to lead the way on insurer profits in Q3. Here's how its competitors fared. pminemyer. Mon, 11/07/2022 - 15:36.

Insurance 133

Insurance 133

PhRMA

NOVEMBER 7, 2022

The United States is facing a crisis of mental health and addiction that has left few Americans and families unimpacted by these illnesses and the devastating consequences that are often associated with them. Mental illness refers to a wide range of mental health conditions that can affect mood, thinking and behavior. These illnesses include substance use disorders and such conditions as depression, anxiety disorders, schizophrenia, bipolar disorder and eating disorders.

176

176

Drug Topics

NOVEMBER 8, 2022

Besides providing education and counseling, pharmacists play a key role in the administration of vaccines.

Vaccines 201

Vaccines 201

Pharmacy Times

NOVEMBER 10, 2022

Expert health professionals share their thoughts on variants of concern vs variants of interest of the SARS-CoV-2 strains as they relate to clinical practice.

139

139

Fierce Pharma

NOVEMBER 8, 2022

Moderna’s Spikevax carries higher risk of myocarditis than Pfizer's Comirnaty, study says. zbecker. Tue, 11/08/2022 - 11:03.

128

128

PharmExec

NOVEMBER 8, 2022

Why enabling a shared culture of quality across an organization is key to maintaining pharma’s recent pace of innovation wins—while inspiring new levels of confidence.

128

128

Drug Topics

NOVEMBER 11, 2022

Collecting data on social determinants of health carries a number of issues and needs to be improved to create learning health systems.

189

189

Pharmacy Times

NOVEMBER 10, 2022

The most common cause of death for patients with non-alcoholic fatty liver disease is cardiovascular disease, but it also increases the risk of hepatocellular carcinoma and may surpass hepatitis B and C as the leading cause of this cancer.

139

139

Fierce Healthcare

NOVEMBER 10, 2022

CMS looking at quality metrics to get ACA exchange plans into value-based care. rking. Thu, 11/10/2022 - 16:00.

126

126

pharmaphorum

NOVEMBER 7, 2022

Blood cells grown in a laboratory have been given to people for the first time in a clinical trial being carried out by researchers in the UK, in the hope that plentiful supplies of rare blood groups can be manufactured to order. A team from the universities of Bristol and Cambridge, NHS trusts and NHS Blood and Transplant (NHSBT) have started giving small quantities of the lab-grown red blood cells – a couple of teaspoons full – to two healthy volunteers to see if they are safe.

126

126

Drug Topics

NOVEMBER 9, 2022

Learn more about the difference between CBD and THC—and why it matters.

187

187

Pharmacy Times

NOVEMBER 9, 2022

The American Heart Association issued a dietary guidance in 2021 suggesting that adults consume a variety of fruits and vegetables, choose whole grains instead of refined grains, eat healthy protein sources and lean cuts of meat, and substitute nonfat and low-fat dairy products for full-fat versions, among other measures.

139

139

Fierce Pharma

NOVEMBER 7, 2022

GSK's CAR-T rival Blenrep fails multiple myeloma trial, endangering its accelerated approval. aliu. Mon, 11/07/2022 - 09:45.

124

124

Fierce Healthcare

NOVEMBER 11, 2022

CMS seeks to close gaps in health equity data collection as new measures roll out. rking. Fri, 11/11/2022 - 15:32.

122

122

Drug Topics

NOVEMBER 9, 2022

As a health plan worked to boost medication adherence among members, it made a startling discovery.

187

187